MAE Group is the capstone between the inventor and the investor. We offer a full bespoke suite of commercialization services to early-stage companies. Our teams will efficiently get through the commercial process, maximize the inventor’s exit strategy, and de-risk
the investor’s funding exposure. We bring medical device and in vitro diagnostic device technology to global markets, allowing the inventor to focus on science and technology and the investor on portfolio management and ROI.